About Index Trending news
Analyze
Pricing

Therapeutics

100+ Companies

Investor

Investments in Therapeutics Geographical focus Market focus Ticket Size Recently active
8
United States Health Care, Biotechnology, Software $700k - $100M
8
United States Health Care, Biotechnology, Medical Devices $1M - $60M
7
United States Technology, Security, Analytics, Health Care, Software, Consumer Internet, Systems $3M - $50M
7
United States Health Care, Biotechnology, Therapeutics $10M - $60M
5
United States Health Care, Biotechnology, Medical Devices $200k - $50M
5
United States Mobile, Health Care, Biotechnology $3M - $30M
4
United States Network Security, Health Care, Biotechnology $8M - $50M
Fidelity Management and Research Company

Fidelity Management and Research Company

4
United States Biotechnology $30M - $80M
OrbiMed

OrbiMed

4
United States and Israel Medical, Health Care, Biotechnology $2M - $90M
4
Health Diagnostics
4
United States Health Care, Biotechnology, Medical Devices $10M - $60M
4
United States Biotechnology $20M - $50M
4
United States and Ireland Enterprise Software, Health Care, Biotechnology $800k - $30M
4
Technology, Life Sciences
4
United States Health Care, Biotechnology, Software $9M - $50M
Pfizer Venture Investments

Pfizer Venture Investments

4
United States Biotechnology $10M - $40M
4
United States Health Care, Biotechnology, Pharmaceuticals $10M - $50M
4
Germany and United States E-Commerce, Biotechnology, Software $300k - $10M
F-Prime Capital Partners

F-Prime Capital Partners

4
United States Health Care, Biotechnology, Health Diagnostics $1M - $60M
Rock Springs Capital

Rock Springs Capital

4
United States Health Care, Biotechnology $30M - $100M
Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund

4
Cormorant Asset Management

Cormorant Asset Management

4
United States Health Care, Biotechnology $20M - $60M
Quark Venture

Quark Venture

3
United States and Canada Biotechnology $2M - $20M
The Royal Society Enterprise Fund

The Royal Society Enterprise Fund

3
3
United States Health Care, Biotechnology, Medical Devices $6M - $40M
Mission Bay Capital

Mission Bay Capital

3
United States Biotechnology $7M - $40M
3
Finance, Banking
3
United States Analytics, Medical, Health Care $6M - $30M
3
Medical, Biotechnology
Sears Capital Management

Sears Capital Management

3
3
United States Health Care, Biotechnology $10M - $40M
Angels5K

Angels5K

3
3
3
United States Health Care, Biotechnology, Software $1M - $50M
Vesalius Biocapital Partners

Vesalius Biocapital Partners

3
3
United States Enterprise Software, Analytics, Software $300k - $20M
3
United States, Canada and Israel Enterprise Software, Health Care, Software $1M - $50M
3
United States Health Care, Biotechnology $500k - $300M
3
3
United Kingdom and United States Biotechnology, Clean Technology $800k - $10M
3
United States Advertising, Security, Biotechnology $900k - $30M
24Haymarket

24Haymarket

3
2
2
United States Health Care, Biotechnology, Medical Devices $7M - $50M
2
Finance
2
United States Biotechnology $10M - $60M
2
Medical, Health Care, Biotechnology, Health Diagnostics
2
United States Health Care, Biotechnology, Medical Devices $10M - $80M
Amgen

Amgen

2
Biotechnology
ProQuest Investments

ProQuest Investments

2
United States Health Care, Biotechnology $5M - $100M
Showing a curated sample of 50 investors in the Therapeutics market.

Want to see the complete list?
Go Pro!